Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Challenges assessing clinical endpoints in early Huntington disease

Paulsen, Jane S., Wang, Chiachi, Duff, Kevin, Barker, Roger, Nance, Martha, Beglinger, Leigh, Moser, David, Williams, Janet K., Simpson, Sheila, Langbehn, Douglas, van Kammen, Daniel P., Price, Kathleen and Rosser, Anne Elizabeth ORCID: 2010. Challenges assessing clinical endpoints in early Huntington disease. Movement Disorders 25 (15) , pp. 2595-2603. 10.1002/mds.23337

Full text not available from this repository.


The basic aim of this study was to evaluate the current accepted standard clinical endpoint for the earliest-studied HD participants likely to be recruited into clinical trials. As the advent of genetic testing for HD, it is possible to identify gene carriers before the diagnosis of disease, which opens up the possibility of clinical trials of disease-modifying treatments in clinically asymptomatic persons. Current accepted standard clinical endpoints were examined as part of a multinational, 32-site, longitudinal, observational study of 786 research participants currently in the HD prodrome (gene-positive but not clinically diagnosed). Clinical signs and symptoms were used to prospectively predict functional loss as assessed by current accepted standard endpoints over 8 years of follow-up. Functional capacity measures were not sensitive for HD in the prodrome; over 88% scored at ceiling. Prospective evaluation revealed that the first functional loss was in their accustomed work. In a survival analysis, motor, cognitive, and psychiatric measures were all predictors of job change. To our knowledge, this is the first prospective study ever conducted on the emergence of functional loss secondary to brain disease. We conclude that future clinical trials designed for very early disease will require the development of new and more sensitive measures of real-life function.

Item Type: Article
Date Type: Publication
Status: Published
Schools: MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Neuroscience and Mental Health Research Institute (NMHRI)
Subjects: R Medicine > R Medicine (General)
Additional Information: Kathleen Price and Anne Rosser are collaborators on this article
Publisher: John Wiley & Sons
ISSN: 0885-3185
Last Modified: 31 Oct 2022 09:18

Citation Data

Cited 59 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item